Skip to content
The Policy VaultThe Policy Vault

isavuconazole — Blue Cross Blue Shield of New Mexico

invasive mucormycosis

Initial criteria

  • Diagnosis of invasive aspergillosis OR invasive mucormycosis OR another FDA labeled or compendia supported indication
  • Patient does NOT have any FDA labeled contraindications to the requested agent

Approval duration

6 months (Ohio Fully Insured/HIM Shop 12 months)